Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans

by Rolin L. Wade, Chi-Chang Chen, Ajita P. De, Jaren C. Howard

Using Real World Evidence to Describe Pulmonary Arterial Hypertension Treatment Patterns, Healthcare Resource Utilization, and Costs Associated with PDE-5 Inhibitor Monotherapy

by George Ruiz, Jason Yeaw, Cassandra A. Lickert, Ajita P. De, Rolin L. Wade, Janis Pruett, William Drake

Adherence and Persistence Patterns in Medication Use Among Men With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia

by Emily Shortridge PhD, Craig Donatucci MD, Prina Donga MS, Michael Marcus MS, Rolin L. Wade MS, RPh
Published 2017-01-01

Medication adherence, hospitalization, and healthcare resource utilization and costs in patients with pulmonary arterial hypertension treated with endothelin receptor antagonists o...

by Robert P. Frantz, Jerrold W. Hill, Cassandra A. Lickert, Rolin L. Wade, Michele R. Cole, Yuen Tsang, William Drake
Published 2020-03-01

Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of...

by Seth J. Baum, Pallavi B. Rane, Sasikiran Nunna, Mohdhar Habib, Kiran Philip, Kainan Sun, Xin Wang, Rolin L. Wade
Published 2021-06-01

Outcome evaluation of a subcutaneous immunoglobulin clinical management program

by Julia Zhu, Gretchen Ayer, Heather S Kirkham, Chi-Chang Chen, Rolin L Wade, Swapna U Karkare, Chester H Robson, Jordan S Orange
Published 2019-01-01